Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).

NCT06431776 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Pulmonary Alveolar Proteinosis

Interventions

DRUG: Molgramostim

Sponsor

Savara Inc.